Patents granted

Tissuemed has announced that two patents for a key component of its underlying technology have been accepted for grant in Eu and USA. The patents, relating to TissuePatch2 cover fundamental elements of the company’s adhesive Terpolymer technology. A more recent filing relating to TissuePatch3 has now been granted in South Africa.

For the company Nick Woods, CEO states; “Tissuemed has always had a policy of robustly protecting its technology and it is always gratifying to receive these notifications as they confirm the claim that what we have is a novel and unique proposition.”